| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.36B | 5.24B | 6.40B | 6.81B | 5.85B |
| Gross Profit | 1.33B | 1.35B | 1.79B | 1.95B | 1.67B |
| EBITDA | 268.50M | 618.70M | 1.01B | 1.18B | 980.40M |
| Net Income | -137.30M | 130.10M | 420.40M | 677.00M | 593.30M |
Balance Sheet | |||||
| Total Assets | 5.31B | 5.68B | 6.23B | 6.32B | 5.42B |
| Cash, Cash Equivalents and Short-Term Investments | 275.70M | 269.80M | 468.60M | 600.10M | 355.30M |
| Total Debt | 2.43B | 2.51B | 2.59B | 2.63B | 1.92B |
| Total Liabilities | 3.69B | 3.79B | 4.14B | 4.28B | 3.51B |
| Stockholders Equity | 1.63B | 1.89B | 2.09B | 2.04B | 1.91B |
Cash Flow | |||||
| Free Cash Flow | 396.30M | 264.00M | 444.30M | 197.80M | 306.90M |
| Operating Cash Flow | 562.10M | 431.40M | 733.60M | 586.10M | 574.00M |
| Investing Cash Flow | -141.60M | -168.90M | -378.90M | -443.20M | -1.35B |
| Financing Cash Flow | -441.30M | -442.70M | -487.00M | 110.80M | 621.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $381.45M | 25.00 | 7.40% | ― | -12.17% | ― | |
68 Neutral | $3.72B | 20.31 | 13.70% | 3.72% | 5.74% | 39.40% | |
67 Neutral | $271.13M | 24.23 | 10.00% | 6.03% | -12.30% | -29.51% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | $5.79B | -41.40 | -7.73% | 2.27% | -4.78% | -189.89% | |
55 Neutral | $592.49M | 42.74 | 3.72% | ― | 11.54% | ― | |
47 Neutral | $212.82M | -1.83 | -35.49% | ― | 5.62% | -1706.59% |
On November 26, 2025, Brunswick Corporation announced the early tender results for its tender offer to purchase $300 million of its 5.100% Senior Notes due 2052. The company increased the tender cap from $50 million to $100 million, and by the early tender deadline, $111 million of notes were tendered. Due to oversubscription, Brunswick will only accept $100 million worth of notes, applying a proration rate of 90.2%. The settlement is expected on December 1, 2025, and no further notes will be accepted after the early tender deadline.
The most recent analyst rating on (BC) stock is a Hold with a $60.00 price target. To see the full list of analyst forecasts on Brunswick stock, see the BC Stock Forecast page.